Home
    • Plans Blog Contact
    High Sierra Technologies, Inc. logo

    High Sierra Technologies, Inc.

    HSTI
    Last price US$1.40
    Market cap US$28.9m
    12M price change 3.70%
    Loading the 12-month Mave Thesis and 1-month news signal

    Industry and sector peers, plus broader research alternatives

    View comparison
    Zoetis IncZTS Industry peer Amphastar PAMPH Industry peer Prestige Consumer HealthcarePBH Industry peer IQVIA Holdings IncIQV Sector peer
    Overview Earnings Report Price History News Competitors Earnings per Share Return on Equity Net Margin Share Buyback Leverage Financial Statements Financial Ratio
    Dashboard Funda..tals Prediction Screener Map

    High Sierra Technologies, Inc. Overview

    Industry: Drug Manufacturers Specialty & Generic

    Sector: Healthcare

    High Sierra Technologies, Inc. focuses on the development of patents and other products used in the processing of recreational cannabis and industrial hemp. Its patent portfolio includes low odor cannabis and hemp for smoking or as the starting materials for producing low odor cannabis and hemp products or flavored cannabis and hemp products. The company is based in Reno, Nevada. High Sierra Technologies, Inc. focuses on the development of patents and other products used in the processing of recreational cannabis and industrial hemp. Its patent portfolio includes low odor cannabis and hemp for smoking or as the starting materials for producing low odor cannabis and hemp prod Read More

    Mavefund brings filings, fundamentals, valuation, price history and news for High Sierra Technologies, Inc. into one research view. The sections below show what strengthens or weakens the research case.

    Score

    Reported Results

    What the company reported, with filing details kept small.

    Filed Dec 15, 2023

    Quarterly result summary

    Latest company-filed earnings material is available for source review.

    What changed

    • Review the SEC source filing for the full reported results and management commentary.

    Guidance / outlook

    No formal outlook was extracted from this filing excerpt. Open the SEC source to review full management commentary.

    SEC filing Open filing

    Source: SEC EDGAR company-filed earnings materials. Dates are shown only for verification; review the source filing before relying on extracted report details.

    Other recent earnings materials
    SEC filing QUARTERLY REPORT ON FORM 10Q FOR THE QUARTER ENDED JUNE 30, 2023 Aug 16, 2023 SEC filing QUARTERLY REPORT ON FORM 10Q FOR THE QUARTER ENDED MARCH 31, 2023 May 22, 2023 SEC filing ANNUAL REPORT ON FORM 10K FOR THE YEAR ENDED DECEMBER 31, 2022 Apr 17, 2023 SEC filing QUARTERLY REPORT ON FORM 10Q FOR THE QUARTER ENDED SEPTEMBER 30, 2022 Nov 18, 2022 SEC filing QUARTERLY REPORT ON FORM 10Q FOR THE QUARTER ENDED JUNE 30, 2022 Aug 15, 2022 SEC filing QUARTERLY REPORT ON FORM 10Q FOR THE QUARTER ENDED MARCH 31, 2022 May 12, 2022 SEC filing ANNUAL REPORT ON FORM 10K FOR THE YEAR ENDED DECEMBER 31, 2021 Mar 21, 2022

    Prediction-grade evidence

    Recent News

    Company-relevant articles from sources that pass the Mave Signal relevance and reliability checks.

    No qualified company news in the last 14 days

    No recent article passed both the company-relevance and source-reliability checks. Research continues to use the other available filings, fundamentals, market data, and valuation inputs.

    Earnings Per Share

    Score 0.00/5
    High Sierra Technologies, Inc. earns a low score, as its Earnings Per Share (EPS) has not shown continuous growth over the last six years. Notable counterparts in the sector with high scores includes Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
    In Drug Manufacturers Specialty & Generic industry , Zoetis Inc , Amphastar P , Prestige Consumer Healthcare are companies with high ratings.

    Return on Equity

    Score 3.53/5
    High Sierra Technologies, Inc. stands out with a superior score in the Return on Equity (ROE) section, surpassing the sector median value and showcasing its strong performance in this metric. The top companies in the same sector include Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
    High Sierra ... HSTI US$28.9m
    Zoetis Inc ZTS US$31.9b
    IQVIA Holdin... IQV US$34.8b
    Agilent Tech... A US$37.9b

    Net Margin

    Score 3.65/5
    High Sierra Technologies, Inc. commands a high score, propelled by its net margin consistently outpacing the sector median value and exhibiting continuous growth in recent six years; noteworthy counterparts in the sector, boasting similarly high scores, include Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
    High Sierra ... HSTI US$28.9m
    Zoetis Inc ZTS US$31.9b
    IQVIA Holdin... IQV US$34.8b
    Agilent Tech... A US$37.9b

    Share Buyback

    In Drug Manufacturers Specialty & Generic industry , Zoetis Inc , Amphastar P , Prestige Consumer Healthcare are companies with high ratings.

    Leverage

    Score 4.30/5
    High Sierra Technologies, Inc. attains a commendable score in the category due to its lower leverage ratio over the past six years in comparison to the sector median value. Additionally, other notable companies in the same sector, such as Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc , also exhibit high scores.
    High Sierra ... HSTI US$28.9m
    Zoetis Inc ZTS US$31.9b
    IQVIA Holdin... IQV US$34.8b
    Agilent Tech... A US$37.9b

    Financial Statements

    Company-reported SEC EDGAR facts organized into the three core statements.

    Verified SEC statements load when this section enters view.

    Source: SEC EDGAR companyfacts. Values are standardized company filings for research support, not personalized financial advice.

    Financial Ratio

    Yearly Quarterly

    Financial
    Profitability
    Growth
    Cash Flow
    Financial Health
    Efficiency Ratios

    High Sierra Technologies, Inc. logo

    High Sierra Technologies, Inc.

    US$1.40

    US$28.9m

    0.00%

    3.70%